These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20201962)

  • 1. Pseudoaneurysm in association with a knee endoprothesis operation in an inhibitor-positive haemophilia A patient - treatment with local thrombin.
    Saarela MS; Tiitola M; Lappalainen K; Vikatmaa P; Pinomäki A; Alberty A; Lassila R
    Haemophilia; 2010 Jul; 16(4):686-8. PubMed ID: 20201962
    [No Abstract]   [Full Text] [Related]  

  • 2. Arterial pseudoaneurysms in haemophilia: conservative treatment with observation and factor replacement.
    Drew M; Yu JC; Michaels LA
    Haemophilia; 2011 May; 17(3):550-2. PubMed ID: 21118336
    [No Abstract]   [Full Text] [Related]  

  • 3. Some recent developments regarding arthropathy and inhibitors in haemophilia.
    Rodriguez-Merchan EC
    Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitors.
    Sartori R; Bisson R; Baars GW; Petris U; Radossi P; Risato R; Tassinari C; Tagariello G
    Haemophilia; 2008 Mar; 14(2):375-7. PubMed ID: 18179576
    [No Abstract]   [Full Text] [Related]  

  • 5. Total knee replacement in patients with haemophilia: the Scottish experience.
    Jenkins PJ; Ekrol I; Lawson GM
    Scott Med J; 2013 Nov; 58(4):223-7. PubMed ID: 24215041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of recombinant factor VIIa: continue or not?
    Ewenstein BM
    Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant factor VIIa in multiple surgery.
    Schulman S; Lindstedt M; Alberts KA; Agren PH
    Thromb Haemost; 1994 Jan; 71(1):154. PubMed ID: 8165636
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt.
    Hurst E; Talks K; Hanley J
    Haemophilia; 2010 Jul; 16(4):708-9. PubMed ID: 20398076
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver transplantation in a patient with mild haemophilia A and low-titres of factor VIII inhibitors treated with recombinant factor VIIa. The first Argentinean case.
    Guglielmone H; Jarchum G; Minoldo S
    Haemophilia; 2011 Mar; 17(2):317-8. PubMed ID: 21332883
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa.
    Lenz E; Repas-Humpe M; Oldenburg J; Kreuz W; Schröter W; Eber SW
    Eur J Pediatr; 1999 Nov; 158(11):951-2. PubMed ID: 10541960
    [No Abstract]   [Full Text] [Related]  

  • 11. Shoulder hemarthrosis due to a bleeding pseudoaneurysm.
    Kang H; Baron M; Glikstein R
    Clin Rheumatol; 2005 Jun; 24(3):305-7. PubMed ID: 15940564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to perform ultrasound-assisted thrombin injection for closure of iatrogenic femoral pseudoaneurysm.
    Batson R; Falterman CJ; Craven J; Kerut EK
    Echocardiography; 2004 Apr; 21(3):295-7. PubMed ID: 15053797
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
    Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M
    Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of high dose factor VIIa in hemophilia patients.
    Hedner U
    Adv Exp Med Biol; 2001; 489():75-88. PubMed ID: 11554593
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia a patient with inhibitor.
    Morimoto Y; Yoshioka A; Shima M; Kirita T
    J Oral Maxillofac Surg; 2003 Sep; 61(9):1095-7. PubMed ID: 12966487
    [No Abstract]   [Full Text] [Related]  

  • 16. Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
    Young G; Shafer FE; Rojas P; Seremetis S
    Haemophilia; 2008 Mar; 14(2):287-94. PubMed ID: 18081834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.
    Bakhtiari K; Kamphuisen PW; Mancuso ME; Hamulyak K; Schutgens RE; Santagostino E; Meijers JC
    Br J Haematol; 2013 Sep; 162(6):827-35. PubMed ID: 23889493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpyelolithotomy renal artery pseudoaneurysm management with percutaneous thrombin injection: a case report.
    Gupta V; Galwa R; Khandelwal N; Bapuraj JR
    Cardiovasc Intervent Radiol; 2008; 31(2):422-6. PubMed ID: 17943349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision.
    Leblebisatan G; Sasmaz I; Antmen B; Kilinc Y; Sizmaz S; Yagmur M
    Haemophilia; 2006 Mar; 12(2):187-9. PubMed ID: 16476096
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
    Steen Carlsson K; Astermark J; Donfield S; Berntorp E
    Thromb Haemost; 2008 Jun; 99(6):1060-7. PubMed ID: 18521509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.